Navigation Links
Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden
Date:9/2/2014

BARCELONA, Spanien, September 2, 2014 /PRNewswire/ --

-- Das auf dem ESC-Kongress 2014 präsentierte GARFIELD-AF-Register bietet einen Einblick in die Behandlung und Behandlungsergebnisse von schlaganfallgefährdeten Patienten in der klinischen Praxis --  

Die Daten der nahezu 12.500 im GARFIELD-AF-Register eingetragenen Patienten, einer innovativen und unabhängigen Forschungsinitiative zur Untersuchung von Vorhofflimmern, haben gezeigt, dass Schlaganfall-Präventionsstrategien für Patienten mit Vorhofflimmern (VF) unverändert subobptimal sind trotz des Übergangs in eine neue Ära der Antikoagulanzientherapien mit oralen Antikoagulanzien (NOAK) (nicht Vitamin-K-Antagonisten). Die diese Woche beim ESC-Kongress 2014 vorgestellten Erkenntnisse zeigen, dass die Behandlungsmuster in der täglichen klinischen Praxis nicht mit den evidenzbasierten Leitlinien übereinstimmen und dass die nicht sachgemäße und unzureichende Nutzung der Antikoagulanzientherapie mit negativen Behandlungsergebnissen assoziiert ist.

GARFIELD-AF wird von einem internationalen Lenkungsausschuss unter der Schirmherrschaft des Thrombosis Research Institute (TRI), London, UK, geführt. Dabei handelt es sich um ein Beobachtungsprogramm mit dem Ziel, die Entwicklung der Behandlung und Behandlungsergebnisse für Patienten, Kliniker und Gesundheitsdienstleister zu verdeutlichen. Die Mehrzahl der bereits erhobenen Daten über VF entstammen kontrollierten klinischen Studien, wohingegen man wesentlich weniger Bescheid weiß über die Belastung der Patienten und Populationen in der klinischen Praxis.  Bis zu 2 % der Population leidet an VF[1] einer verbreiteten Herzrhythmusstörung, die zu lebensbedrohlichen Komplikationen wie Schlaganfall führen kann. Trotz der Verfügbarkeit von ho
'/>"/>

SOURCE GARFIELD-AF
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. MediSapiens liefert neue Cloud-Computing-App zur Analyse und Visualisierung multidimensionaler Genomdaten an Bayer HealthCare Pharmaceuticals
2. Langfristige Verlaufskontrolldaten zum WEB Aneurysma-Embolisations-System zeigen hohe Raten von stabiler Okklusion bei schwierig zu behandelnden Aneurysmen
3. e-novex veröffentlicht edc2go: hochqualitative und kostensparende elektronische Datenerfassung
4. ideaPoint Inc. präsentiert Multi-Sponsor-Portal für Forscheranfragen an fünf globale Studiensponsoren bezüglich Zugang zu Daten aus klinischen Studien
5. Bewerber für den mit 1.000.000 $ ausgestatteten globalen B.R.A.I.N.-Preis gesucht
6. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
7. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
8. Attendees Save up to $350 on CHI Conferences This Summer by Registering Through Global Information
9. Worlds Only USDA Certified Organic and FDA Registered Homeopathic Medicines Guaranteed to Work
10. DATATRAK Expands CDISC Registered Solutions Provider Standards
11. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , Chief Financial Officer of Neurocrine Biosciences, will be ... New York City . The ... 11:25am ET (8:25am PT).  The presentation will be webcast ... http://www.neurocrine.com .   Listeners are encouraged ...
(Date:9/2/2015)... -- Research and Markets ( ... PharmaBiotech,s new report "Therapeutic Drug Monitoring - ... This report deals with therapeutic drug ... patient care by monitoring drug levels in the ... for improving outcome. TDM is viewed as a ...
(Date:9/2/2015)... MARIETTA, Ga. , Sept. 2, 2015  MiMedx ... regenerative medicine company utilizing human amniotic tissue and ... and therapies for the Wound Care, Surgical, Orthopedic, ... healthcare, today corrected the inaccurate statements published by ... release of September 1, 2015. MTF,s ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2MiMedx Corrects A Second Inaccurate MTF Press Release 2MiMedx Corrects A Second Inaccurate MTF Press Release 3
... Inc., a privately,held biopharmaceutical company that specializes ... ophthalmic,pharmaceuticals, today reported the interim month three ... pharmacokinetic (PK) study of Medidur(TM) FA,which Alimera ... Iluvien(TM),if approved by the U.S. Food and ...
... developing proposals to fund clinical studies for early detection ... ... 25 Biomoda, Inc. (OTC,Bulletin Board: BMOD) ( http://www.biomoda.com ), a ... the Small,Business Innovation Research (SBIR) and Small Business Technology Transfer,(SBTT) seed ...
Cached Medicine Technology:Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study 2Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study 3Small Business Innovation Research Program Awards Grant to Biomoda 2
(Date:9/3/2015)... ... 03, 2015 , ... Doctor Kayode Sotonwa can be counted on ... perspective on internal medicine keeps patients happy and healthy, something that is important to ... the season, but even more so in the fall, when holiday eating and seasonal ...
(Date:9/2/2015)... ... September 03, 2015 , ... Leah ... among the most influential leaders in healthcare, will offer the keynote address at ... place October 15-16, 2015, in Palm Harbor, Florida, at the Innisbrook Resort and ...
(Date:9/2/2015)... ... 02, 2015 , ... The CRISPR-Cas9 system introduces double-strand DNA breaks ... nuclease with either a chimeric single guide RNA (sgRNA) or two short RNAs (a ... RNA (sgRNA or crRNA) to create a break in the target DNA that causes ...
(Date:9/2/2015)... ... ... to an article published August 12 by International Business Times, a new bill ... grand juries in cases meant to decide if a police officer used deadly or excessive ... in Ferguson and New York City that absolved police officers of charges in the deaths ...
(Date:9/2/2015)... Lauderdale, FL (PRWEB) , ... September 02, 2015 ... ... for Amgen’s Blincyto® (blinatumomab) – in the news recently following a decision by ... hospitalized Medicare patients – is likely to average approximately $71,000 or roughly 40% ...
Breaking Medicine News(10 mins):Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 4
... study to identify the composition of bacterial populations on the ... Skin, which// is the largest organ in our body harbors ... previously. Researchers said that it appears that the skin, is ... quite novel. ,Researchers found evidence for 182 species ...
... during pregnancy could lead to diabetes and cardio vascular ... women. Among them, those who had a high BP ... atherosclerosis than their counterparts who had a normal BP. ... latest issue of ‘Hypertension’ suggests that calcification of the ...
... latest Government data, there is an alarming rise in suicides ... linked to the plummeting sale of// antidepressants. ,This ... also indicated that youth in their late teens resorted to ... Administration had issued a black box warning on the antidepressants ...
... conducted by Robert Wilson of Rush University Medical Centre of Chicago ... Alzheimer’s like// Dementia. People who are single or socially secluded are ... their life. ,According to this study, a group of ... age group of 80 for a period of four years. A ...
... Worldwide describes a lawsuit from CSPI -Center for Science in ... claims of their new drink. ,According to the ... more calories and hence, an aid to calorie ... soft drink is laced with EGCG or epigallocatechin gallate which ...
... pain in the jaw may be a sign of a heart ... Uruguay.// ,The symptoms are however often overlooked, and especially ... tooth or jaw ache without chest pains, the study said. ... were asked to indicate on a body chart where they experienced ...
Cached Medicine News:Health News:Human Skin Harbors Many More Types of Bacteria 2Health News:Human Skin Harbors Many More Types of Bacteria 3Health News:Human Skin Harbors Many More Types of Bacteria 4Health News:Human Skin Harbors Many More Types of Bacteria 5Health News:Support Claims With Science Not Magic, Beverage Owners Warned 2
Detection of Malarial antigen in Human whole blood....
Malaria ( P. Falciparum ) Whole Blood Strip / Cassette...
This is an antigen-capture assay intended for the detection of histidine-rich protein ll (PfHRP-ll), which is released from Malaria-infected red blood cells....
OptiMAL is a malaria test, for diagnosis and therapy control of an infection by Plasmodium species (Malaria)....
Medicine Products: